| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/28/1998 | EP0706379B1 Soft gelatin capsule shell compositions |
| 01/28/1998 | EP0688207B1 Lipid-polymer conjugates and liposomes |
| 01/28/1998 | EP0654046B1 Auto-cross-linked gellan gum |
| 01/28/1998 | EP0609336B1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 01/28/1998 | EP0608320B1 Enhanced skin penetration system for improved topical delivery of drugs |
| 01/28/1998 | CN1171740A Oral compositions containing ondansetron |
| 01/28/1998 | CN1171738A Pharmaceutical composition |
| 01/28/1998 | CN1171736A Matrix type patch preparations |
| 01/28/1998 | CN1171270A Pharmaceutical composition based on stabilized lipophilic matrices for controlled release of active principles |
| 01/28/1998 | CN1171269A Drug administration composition for iontophoresis |
| 01/28/1998 | CN1037149C Phospholipid-contg. composition and its preparation and use as excipient for pharmaceutical substances |
| 01/28/1998 | CN1037148C Stable oral zinc compound |
| 01/27/1998 | US5712391 Polysiloxanes modified with triazine groups and diamine compounds for cosmetics |
| 01/27/1998 | US5712374 Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| 01/27/1998 | US5712310 Suspension of substantially water-insoluble drugs and methods of their manufacture |
| 01/27/1998 | US5712260 Estramustine formulations with improved pharmaceutical properties |
| 01/27/1998 | US5711983 Dinoflagellate biomass, methods for its production, and compositions containing the same |
| 01/27/1998 | US5711968 Composition and method for the controlled release of metal cation-stabilized interferon |
| 01/27/1998 | US5711954 Stable imidazole anti-fungal powder compositions |
| 01/27/1998 | US5711951 Aqueous product comprising discrete, stabilized, microdroplets of an oil and an in situ polymerized vinyl monomer, containing a thickening agent to homogeneously suspend the microdroplets throughout the medium |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/27/1998 | US5711933 Method of making polymeric gas or air filled microballoons for ultrasonic echography |
| 01/27/1998 | CA2194564C Aqueous risperidone formulations |
| 01/27/1998 | CA2015632C Stable solutions of rebeccamycin analog and preparations thereof |
| 01/22/1998 | WO1998002454A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | WO1998002451A1 Oligopeptide transporters |
| 01/22/1998 | WO1998002240A1 Preservation by foam formation |
| 01/22/1998 | WO1998002196A1 A hydrocolloid wound gel |
| 01/22/1998 | WO1998002191A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002189A2 Method for preparing bioactive polymers |
| 01/22/1998 | WO1998002188A1 Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 01/22/1998 | WO1998002187A1 Pharmaceutical composition containing acid addition salt of basic drug |
| 01/22/1998 | WO1998002186A1 Inclusion complex containing indole selective serotonin agonist |
| 01/22/1998 | WO1998002185A1 Quickly disintegrable compression-molded materials and process for producing the same |
| 01/22/1998 | WO1998002184A1 Topical phospholipid-containing acyclovir preparation |
| 01/22/1998 | WO1998002168A1 Complexes of n'-dimethylaminoacetylpartricin a dimethylaminoethylamide, or the salts thereof, and cholesterol 3-sulphate |
| 01/22/1998 | WO1998002148A2 Pharmaceutical composition |
| 01/22/1998 | WO1998002146A2 Chemo-mechanical expansion delivery system |
| 01/22/1998 | WO1998002143A1 An orally administrable, paste-like composition for veterinary use, a method for the preparation thereof, and the use of an oily vehicle for the manufacture of such composition |
| 01/22/1998 | WO1998002142A1 Temperature sensitive gel for sustained delivery of protein drugs |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |
| 01/22/1998 | DE19654468C1 Flexible dermal or transdermal plaster for drug or cosmetic release |
| 01/22/1998 | CA2260967A1 Temperature sensitive gel for sustained delivery of protein drugs |
| 01/22/1998 | CA2260324A1 Method for preparing bioactive polymers |
| 01/22/1998 | CA2260288A1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2260233A1 A scalable method of preserving biologically active materials by desiccation |
| 01/22/1998 | CA2260038A1 Quickly disintegratable compression-molded materials and process for producing the same |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2260029A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | CA2259418A1 Pharmaceutical composition containing acid addition salt of basic drug |
| 01/22/1998 | CA2257860A1 Inclusion complex containing indole selective serotonin agonist |
| 01/22/1998 | CA2230656A1 Chemo-mechanical expansion delivery system |
| 01/21/1998 | EP0819438A2 Buprenorphine percutaneous absorption preparation |
| 01/21/1998 | EP0819434A1 Use of PHMB for the treatment of tumors |
| 01/21/1998 | EP0819429A1 Direct tabletting aid |
| 01/21/1998 | EP0819426A2 Alpha,omega-polyetherpolysiloxanes as W/O emulsifiers |
| 01/21/1998 | EP0819418A1 Composition comprising a hydrophilic compound and the association of a volatile compound and a pasty fatty compound and use of same association |
| 01/21/1998 | EP0819144A1 Microgels |
| 01/21/1998 | EP0819136A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
| 01/21/1998 | EP0819010A1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution |
| 01/21/1998 | EP0819009A1 Ovulation triggering drugs |
| 01/21/1998 | EP0819008A1 Method of using lectins for prevention and treatment of skin diseases and disorders |
| 01/21/1998 | EP0819004A1 Pharmaceutical composition containing proton pump inhibitors |
| 01/21/1998 | EP0818998A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions |
| 01/21/1998 | EP0818994A1 Method of making a pressure sensitive skin adhesive sheet material |
| 01/21/1998 | EP0818991A1 Controlled release insufflation carrier for medicaments |
| 01/21/1998 | EP0818990A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
| 01/21/1998 | EP0818989A1 Novel compositions of lipids and stabilizing materials |
| 01/21/1998 | EP0729353A4 Preparation of biodegradable microparticles containing a biologically active agent |
| 01/21/1998 | CN1171054A Compound |
| 01/21/1998 | CN1171052A Vaccine adjuvants |
| 01/21/1998 | CN1171049A Powder formulations containing melezitose as diluent |
| 01/21/1998 | CN1171047A Proliposome powder for inhalation |
| 01/21/1998 | CN1171046A Aerosol formulations of peptides and proteins |
| 01/21/1998 | CN1171045A Hemorrhoidal compositions and method of use |
| 01/21/1998 | CN1170610A Direct tabletting aids |
| 01/21/1998 | CN1037063C Preparation method for antibacterial composition of oral administration |
| 01/20/1998 | US5710257 Method of causing selective immunosuppression using HL-60-related lectins |
| 01/20/1998 | US5710183 And optionally a wetting aagent and gas reducing agent; improved bowel function |
| 01/20/1998 | US5710182 Topical solution of active agent, hydrophilic polymer, salt, wetting agent, preservative, water |
| 01/20/1998 | US5710177 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair & nails |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/20/1998 | US5709885 Process for the preparation of drug pellets |
| 01/20/1998 | US5709884 Process for conditioning substances |
| 01/20/1998 | US5709883 Solubilized in polymer matrix blend; sustained release |
| 01/20/1998 | US5709882 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as a process for the preparation thereof |
| 01/20/1998 | US5709881 Tablet capsule or granule comprising desogestrel |
| 01/20/1998 | US5709878 Transdermal delivery of dehydroepiandrosterone |
| 01/20/1998 | US5709876 Saccharide-based matrix |
| 01/20/1998 | US5709869 Intradermal delivery of lidocaine |
| 01/20/1998 | US5709861 Compositions for the delivery of antigens |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/20/1998 | US5709851 Preparing a stable, aqueous iodine composition |
| 01/19/1998 | CA2210597A1 Buprenorphine percutaneous absorption preparation |
| 01/17/1998 | CA2210173A1 Composition comprising a hydrophilic compound and the combination of a volatile compound and a pasty fat compound and use of this combination |
| 01/15/1998 | WO1998001555A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 01/15/1998 | WO1998001547A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 01/15/1998 | WO1998001421A1 pH SENSITIVE HYDROGELS WITH ADJUSTABLE SWELLING KINETICS FOR COLON-SPECIFIC DELIVERY OF PEPTIDES AND PROTEINS |